Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02603822 · ClinicalTrials.gov registry record · Phase 1
Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT02603822: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT02603822 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02603822, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The investigators' overall objective with this study is to determine performance characteristics of small intestine permeability measurement using 13C mannitol and 12C (regular) mannitol.
Interventions
- DRUG Indomethacin
- DIETARY_SUPPLEMENT 12C mannitol
- DIETARY_SUPPLEMENT 13C mannitol
- DIETARY_SUPPLEMENT Lactulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-08 |
| Est. Completion | 2018-07-17 |
| Phase | Phase 1 |
What the finished NCT02603822 record still lists
NCT02603822 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (58% lower).
The record links to 0 conditions, and to 4 interventions - of which Indomethacin is the first listed.
NCT02603822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02603822 about?
NCT02603822 is a clinical study titled "Performance of 13C Mannitol for in Vivo Measurement of Small Intestinal Permeability". The investigators' overall objective with this study is to determine performance characteristics of small intestine permeability measurement using 13C mannitol and 12C (regular) mannitol.
What is the current status of trial NCT02603822?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2015-08. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT02603822?
The interventions under investigation include: Indomethacin (DRUG), 12C mannitol (DIETARY_SUPPLEMENT), 13C mannitol (DIETARY_SUPPLEMENT), Lactulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02603822?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02603822's enrollment target sits among peer trials
25 1495th of 2000 higher than 481 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia